Xinghui Tian
Overview
Explore the profile of Xinghui Tian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shafa M, Walsh T, Panchalingam K, Richardson T, Menendez L, Tian X, et al.
Int J Mol Sci
. 2019 Dec;
21(1).
PMID: 31877913
The clinical effectiveness of human induced pluripotent stem cells (iPSCs) is highly dependent on a few key quality characteristics including the generation of high quality cell bank, long-term genomic stability,...
2.
Ahmadian Baghbaderani B, Tian X, Cadet J, Shah K, Walde A, Tran H, et al.
PLoS One
. 2016 Sep;
11(9):e0161229.
PMID: 27606941
Human pluripotent stem cells (hPSCs) present an unprecedented opportunity to advance human health by offering an alternative and renewable cell resource for cellular therapeutics and regenerative medicine. The present demand...
3.
Ahmadian Baghbaderani B, Tian X, Neo B, Burkall A, Dimezzo T, Sierra G, et al.
Stem Cell Reports
. 2015 Sep;
5(4):647-59.
PMID: 26411904
The discovery of induced pluripotent stem cells (iPSCs) and the concurrent development of protocols for their cell-type-specific differentiation have revolutionized our approach to cell therapy. It has now become critical...
4.
Hexum M, Tian X, Kaufman D
Methods Mol Biol
. 2011 Aug;
767:433-47.
PMID: 21822894
Efficient derivation and isolation of hematopoietic stem cells (HSCs) from human pluripotent stem cell (hPSC) populations remains a major goal in the field of developmental hematopoiesis. These enticing pluripotent stem...
5.
Tian X, Hexum M, Penchev V, Taylor R, Shultz L, Kaufman D
Stem Cells
. 2009 Aug;
27(11):2675-85.
PMID: 19711457
Human embryonic stem cells (hESCs) provide an important resource for novel regenerative medicine therapies and have been used to derive diverse cell populations, including hematopoietic and endothelial cells. However, it...
6.
Woll P, Grzywacz B, Tian X, Marcus R, Knorr D, Verneris M, et al.
Blood
. 2009 Apr;
113(24):6094-101.
PMID: 19365083
Natural killer (NK) cells serve as important effectors for antitumor immunity, and CD56+CD45+ NK cells can be routinely derived from human embryonic stem cells (hESCs). However, little is know about...
7.
Tian X, Kaufman D
Curr Opin Hematol
. 2008 Jun;
15(4):312-8.
PMID: 18536568
Purpose Of Review: Hematopoietic development from embryonic stem cells has been one of the most productive areas of stem cell biology. Recent studies have progressed from work with mouse to...
8.
Tian X, Kaufman D
Methods Mol Biol
. 2008 Mar;
430:119-33.
PMID: 18370295
The successful isolation and characterization of human embryonic stem cells (hESCs) provides a powerful tool to study the cellular and genetic mechanisms that mediate cell-fate decisions toward distinct developmental lineages....
9.
Wilber A, Linehan J, Tian X, Woll P, Morris J, Belur L, et al.
Stem Cells
. 2007 Aug;
25(11):2919-27.
PMID: 17673526
Efficient and stable genetic modification of human embryonic stem (ES) cells is required to realize the full scientific and potential therapeutic use of these cells. Currently, only limited success toward...
10.
Tian X, Woll P, Morris J, Linehan J, Kaufman D
Stem Cells
. 2006 Feb;
24(5):1370-80.
PMID: 16456127
Human embryonic stem cells (hESCs) provide an important means to characterize early stages of hematopoietic development. However, the in vivo potential of hESC-derived hematopoietic cells has not been well defined....